Cargando…
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response
For pediatric patients with high‐grade gliomas, standard‐of‐care treatment includes surgery, chemotherapy, and radiation therapy; however, most patients ultimately succumb to their disease. With advances in genomic characterization of pediatric high‐grade gliomas, the use of targeted therapies in co...
Autores principales: | Valiakhmetova, Andge, Gorelyshev, Sergey, Konovalov, Alexander, Trunin, Yuri, Savateev, Alexander, Kram, David E., Severson, Eric, Hemmerich, Amanda, Edgerly, Claire, Duncan, Daniel, Britt, Nicholas, Huang, Richard S.P., Elvin, Julia, Miller, Vincent, Ross, Jeffrey S., Gay, Laurie, McCorkle, Joshua, Rankin, Andrew, Erlich, Rachel L., Chudnovsky, Yakov, Ramkissoon, Shakti H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011619/ https://www.ncbi.nlm.nih.gov/pubmed/32043779 http://dx.doi.org/10.1634/theoncologist.2019-0603 |
Ejemplares similares
-
The experience of successful treatment of ETV6-NTRK3-positive infant glioblastoma with entrectinib
por: Papusha, Ludmila, et al.
Publicado: (2021) -
Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
por: File, Danielle M., et al.
Publicado: (2020) -
Olaparib in the Setting of Radiotherapy-Associated Sarcoma: What Can Precision Medicine Offer For Rare Cancers?
por: Hamdan, Diaddin, et al.
Publicado: (2023) -
Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin
por: Lin, Douglas I., et al.
Publicado: (2020) -
Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
por: Burgess, Brian T., et al.
Publicado: (2020)